InvestorsHub Logo
Followers 44
Posts 2774
Boards Moderated 0
Alias Born 02/26/2004

Re: starkd748 post# 177

Friday, 02/20/2015 8:15:32 AM

Friday, February 20, 2015 8:15:32 AM

Post# of 329
Can you link the ct order and where you saw the pathogen reduction instead of inactivation? Thanks!

From the website

The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CERS News